Compound Evidence File
#EC-2026-0348
ARA-290
Filed under Peptides. The bureau holds 169 laboratory returns for this compound from 58 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
58 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 10.0 | 10.0 | 26 Apr 2026 | 28 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 10.0 | 10.0 | 6 May 2026 | 7 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 9.9 | 10.0 | 1 Mar 2026 | 27 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 4 | 10.0 | 10.0 | 10.0 | 3 Apr 2026 | 18 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 10.0 | 9.9 | 10.0 | 22 Apr 2026 | 22 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 10.0 | 10.0 | 19 Jan 2026 | 25 Apr 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 6 May 2026 | 17 May 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Feb 2026 | 24 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 15 Feb 2026 | 23 Apr 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 3 | 10.0 | 9.9 | 10.0 | 25 Apr 2026 | 10 Jul 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 12 Dec 2025 | 9 Apr 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 19 Jun 2026 | 1 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 10.0 | 10.0 | 10.0 | 26 Feb 2026 | 13 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 10.0 | 10.0 | 10.0 | 20 Apr 2026 | 24 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 16 Jan 2026 | 8 Mar 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 17 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 9.9 | 9.9 | 10.0 | 9 Mar 2026 | 23 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 16 Mar 2026 | 5 Jul 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 9.9 | 9.9 | 10.0 | 2 Feb 2026 | 8 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 22 Feb 2026 | 19 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 9.9 | 3 Jul 2026 | 16 Aug 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 2 | 8.8 | 7.7 | 9.9 | 24 May 2026 | 24 May 2026 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 2 | 8.7 | 8.2 | 9.2 | 7 May 2025 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.6 | 6.8 | 9.9 | 21 May 2026 | 21 May 2026 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 3 | 8.4 | 7.3 | 9.6 | 7 May 2025 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 8.2 | 8.0 | 8.4 | 21 May 2026 | 21 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 5 | 8.2 | 6.3 | 10.0 | 2 Jul 2025 | 24 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 8.2 | 7.5 | 9.0 | 2 Jul 2025 | 26 Jan 2026 |
| Skye PeptidesCASE #VI-2026-0451 | X | 6 | 8.0 | 5.3 | 10.0 | 9 Jun 2025 | 20 May 2026 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 8.0 | 8.0 | 8.0 | 21 May 2025 | 21 May 2025 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 8.0 | 8.0 | 8.0 | 13 Feb 2025 | 13 Feb 2025 |
| Eternal PeptidesCASE #VI-2026-0842 | X | 2 | 7.9 | 6.9 | 8.8 | 13 Jun 2025 | 17 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 7.8 | 6.0 | 8.9 | 23 May 2026 | 23 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 2 | 7.7 | 7.4 | 8.0 | 6 May 2025 | 24 May 2026 |
| Nanjing Xiyuxun Technology XYXCASE #VI-2026-0433 | X | 1 | 7.6 | 7.6 | 7.6 | 6 May 2025 | 6 May 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 7.5 | 6.0 | 8.5 | 24 May 2026 | 24 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | X | 2 | 7.5 | 7.4 | 7.6 | 14 Jan 2025 | 21 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 2 | 7.2 | 6.9 | 7.5 | 14 Jan 2025 | 21 May 2026 |
| Peptide-SCASE #VI-2026-0111 | X | 11 | 7.1 | 5.6 | 9.4 | 28 Mar 2025 | 23 May 2026 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 | 11 Jun 2025 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 6.9 | 6.9 | 6.9 | 3 Jun 2025 | 3 Jun 2025 |
| OupeptideCASE #VI-2026-0435 | X | 10 | 6.7 | 4.4 | 8.5 | 2 Jul 2025 | 24 May 2026 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 1 | 6.3 | 6.3 | 6.3 | 3 Jul 2025 | 3 Jul 2025 |
| Zhang TYCASE #VI-2026-0070 | X | 1 | 5.9 | 5.9 | 5.9 | 11 Jun 2025 | 11 Jun 2025 |
| HXNetCASE #VI-2026-0061 | X | 4 | 5.7 | 3.4 | 7.4 | 3 Jul 2025 | 20 May 2026 |
| Platinum CryoCASE #VI-2026-0406 | X | 1 | 5.7 | 5.7 | 5.7 | 24 Apr 2025 | 24 Apr 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 3 | 5.6 | 5.1 | 5.9 | 8 Jul 2025 | 24 May 2026 |
| WllyBIOCASE #VI-2026-0470 | X | 1 | 5.4 | 5.4 | 5.4 | 3 Jun 2025 | 3 Jun 2025 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 4.9 | 4.9 | 4.9 | 7 May 2025 | 7 May 2025 |
| ZhuoYan labCASE #VI-2026-0902 | X | 3 | 4.7 | 4.3 | 5.1 | 17 Dec 2024 | 19 Jan 2026 |
| Amino AmigosCASE #VI-2026-0061 | X | 1 | 3.0 | 3.0 | 3.0 | 24 Apr 2025 | 24 Apr 2025 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 2.3 | 2.3 | 2.3 | 13 Jun 2025 | 13 Jun 2025 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 2.1 | 2.1 | 2.1 | 2 Jul 2025 | 2 Jul 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
| Coffee and PeppersCASE #VI-2026-0274 | X | 1 | 0.0 | 0.0 | 0.0 | 7 May 2025 | 7 May 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 0.0 | 0.0 | 0.0 | 25 Apr 2025 | 25 Apr 2025 |
Open any subject to view the batch-level evidence for ARA-290 alone.